We are live on ! Find out more
HQY icon

HealthEquity

317 hedge funds and large institutions have $5.21B invested in HealthEquity in 2019 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 121 increasing their positions, 102 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

63% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 35

34% more capital invested

Capital invested by funds: $3.88B → $5.21B (+$1.33B)

19% more repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 102

5% more funds holding

Funds holding: 303317 (+14)

2.25% more ownership

Funds ownership: 96.99%99.25% (+2.3%)

58% less call options, than puts

Call options by funds: $11.1M | Put options by funds: $26.3M

Holders
317
Holders Change
+14
Holders Change %
+4.62%
% of All Funds
6.25%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.14%
New
57
Increased
121
Reduced
102
Closed
35
Calls
$11.1M
Puts
$26.3M
Net Calls
-$15.2M
Net Calls Change
-$4.04M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$660M +$18.2M +291,388 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$493M +$2.36M +37,777 +0.6%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$292M +$31.6M +505,907 +15%
JSP
4
Jackson Square Partners
California
$264M +$11.9M +190,506 +6%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$177M +$15.4M +246,804 +12%
State Street
6
State Street
Massachusetts
$162M +$72.8K +1,167 +0.1%
WA
7
Wasatch Advisors
Utah
$162M +$21.1M +337,736 +18%
FAM
8
Fred Alger Management
New York
$133M +$20.2M +323,931 +22%
Wells Fargo
9
Wells Fargo
California
$123M +$9.27M +148,545 +10%
Invesco
10
Invesco
Georgia
$113M -$34.7M -556,150 -27%
Morgan Stanley
11
Morgan Stanley
New York
$84.9M +$4.3M +68,857 +6%
Northern Trust
12
Northern Trust
Illinois
$83.5M +$184K +2,950 +0.3%
BAMCO Inc
13
BAMCO Inc
New York
$78.4M +$68.6K +1,100 +0.1%
JP Morgan Chase
14
JP Morgan Chase
New York
$77.3M +$1.95M +31,254 +3%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$75M -$5.45M -87,373 -8%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$64.4M +$97.2K +1,558 +0.2%
Franklin Resources
17
Franklin Resources
California
$63.1M -$13.3K -213 -0%
Victory Capital Management
18
Victory Capital Management
Texas
$61.1M +$2.55M +40,796 +5%
TCM
19
TimesSquare Capital Management
New York
$59.8M +$10.9M +174,915 +28%
SIMG
20
Stephens Investment Management Group
Texas
$59.5M +$19.1M +306,318 +62%
Ameriprise
21
Ameriprise
Minnesota
$58.9M +$21.5M +344,886 +77%
ESCM
22
Echo Street Capital Management
New York
$53.2M +$7.55M +120,995 +20%
CS
23
Credit Suisse
Switzerland
$52.3M +$492K +7,885 +1%
Norges Bank
24
Norges Bank
Norway
$51.5M
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$49.2M +$2.65M +42,404 +7%

HQY Hedge Fund Activity: Q4 2019 in Review

317 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q4 2019, worth a combined $5.21B — up 34% from $3.88B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HQY positions and 35 closed out — a net gain of 22 holders — while 121 added to existing stakes and 102 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31.6M. The largest seller was Renaissance Technologies, cutting an estimated $53.5M.

  • 317 institutional investors held HealthEquity (HQY) as of Q4 2019, up from 303 in Q3 2019.
  • Funds reported $5.21B of HealthEquity stock for Q4 2019, up 34% quarter-over-quarter.
  • 57 funds opened new HealthEquity positions in Q4 2019 and 35 closed out, a net change of +22 holders.
  • The largest HealthEquity buyer in Q4 2019 was Fidelity Investments, an estimated $31.6M added.
  • The largest HealthEquity seller in Q4 2019 was Renaissance Technologies, an estimated $53.5M sold.

Based on aggregated 13F filings for Q4 2019.